Apollo Hospitals Enterprise Limited has received the certified true copy of an order dated May 5, 2026, passed by the Hon'ble National Company Law Tribunal (NCLT), Division Bench – II, Chennai. The order, uploaded on the Tribunal's website on May 7, 2026, was received by the company on May 8, 2026, and has been disclosed under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Background of the Composite Scheme

The disclosure is in continuation of the company's earlier intimation dated April 27, 2026, regarding a proposed composite scheme of arrangement. The scheme involves Apollo Hospitals Enterprise Limited as the primary company, Apollo Healthco Limited as Transferor Company 1, Keimed Private Limited as Transferor Company 2, and Apollo Healthtech Limited as the Resultant Company, along with their respective shareholders and creditors. The scheme has been filed under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013, read with the rules made thereunder, vide petition number C.A.(CAA)/8(CHE)2026.

NCLT Order: Rescheduling of Stakeholder Meetings

The NCLT order addressed three interlocutory applications — IA(COMPANIES.ACT)/120(CHE)2026, IA(COMPANIES.ACT)/129(CHE)2026, and IA(COMPANIES.ACT)/119(CHE)2026 — each filed by the applicants seeking modification of the dates for convening stakeholder meetings. The Tribunal, considering the submissions made by Senior Counsel Mr. P.H. Aravindh Pandian and counsels from Shardul Amarchand Mangaldas & Co., allowed all three applications and rescheduled the meetings accordingly.

The revised meeting schedule, as approved by the Tribunal, is as follows:

Quorum Remains Unchanged

While the applicants also sought a revision to the quorum for the meetings, the Tribunal declined this request. The NCLT noted that the quorum for all meetings was set vide its earlier order dated March 26, 2026, and that this quorum remains intact and cannot be changed. All three applications were allowed and disposed of on these terms.

Authorised Signatory

The disclosure was signed by SM Krishnan, Sr. Vice President – Finance and Company Secretary of Apollo Hospitals Enterprise Limited, on May 8, 2026. The certified true copy of the order was issued by the Joint Registrar of the NCLT Chennai Bench on May 8, 2026, following an application made on May 7, 2026.

Apollo Hospitals Enterprise Ltd. recorded a block trade on the National Stock Exchange (NSE), with the transaction valued at ₹40.52 crores. The trade involved approximately 52,208 shares executed at a price of ₹7761.00 per share.

Block Trade Details

The following table summarises the key parameters of the block trade:

Block trades are large, privately negotiated transactions that are executed outside of the open market order book, typically involving institutional investors or significant stakeholders. Such trades are reported separately on the exchange to ensure transparency and regulatory compliance.